[1]李墨奇伍薇何文昌余露邹芳谭晶鑫王代红陈锦.构建急性肾损伤患者连续性肾脏替代治疗剂量达成模型[J].中国卫生质量管理,2022,29(01):074-81.[doi:10.13912/j.cnki.chqm.2022.29.1.19 ]
　LI Moqi,WU Wei,HE Wenchang.Construction of the Dose Attainment Model of Continuous Renal Replacement Therapy in Patients with Acute Kidney Injury[J].Chinese Health Quality Management,2022,29(01):074-81.[doi:10.13912/j.cnki.chqm.2022.29.1.19 ]
点击复制

构建急性肾损伤患者连续性肾脏替代治疗剂量达成模型
分享到：

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第29卷
期数:
2022年01期
页码:
074-81
栏目:
QC小组平台
出版日期:
2022-01-28

文章信息/Info

Title:
Construction of the Dose Attainment Model of Continuous Renal Replacement Therapy in Patients with Acute Kidney Injury
作者:
李墨奇伍薇何文昌余露邹芳谭晶鑫王代红陈锦
陆军军医大学新桥医院
Author(s):
LI Moqi; WU Wei; HE Wenchang
Xinqiao Hospital, Army Medical Universty
关键词:
品管圈; 课题研究型品管圈; 急性肾损伤; 连续性肾脏替代治疗; 治疗剂量; 医疗质量
Keywords:
Quality Control Circle;  Project Research Type Quality Control Circle;  Acute Kidney Injury;  Continuous Renal Replacement Therapy;  Medical Quality
分类号:
R197.323;R692
DOI:
10.13912/j.cnki.chqm.2022.29.1.19
文献标志码:
B
摘要:
按照课题研究型品管圈活动步骤，针对急性肾损伤患者连续性肾脏替代治疗处方治疗剂量与实际治疗剂量存在较大差异的现状，对剂量管理现状、攻坚点进行分析与发掘，针对性拟定对策并实施，包括建立集束化血管通路管理策略，制定最优滤器管路使用技术方案，构建全流程CRRT智能管理平台。活动开展后，CRRT治疗剂量达成率由78.5%上升至93.5%，治疗时间达成率、平均CRRT治疗日、28 d存活率、出院时透析依赖率等均有不同程度改善，活动效果显著。
Abstract:
According to the steps of the project research type Quality Control Circle (QCC) activity, in view of the difference between prescription treatment dose and actual treatment dose of the Continuous Renal Replacement Therapy (CRRT) in patients with acute kidney injury, the present situation and the crucial point of the dose management were analyzed and mined. The corresponding countermeasures were proposed and implemented, including establishing cluster vascular access management strategy, formulating the optimal filter pipe using technical scheme, building CRRT intelligent management platform for the whole process. After improvement, the treatment dose achievement rate of CRRT increased from 78.5% to 93.5%, and the achievement rate of treatment time, average treatment day of CRRT, 28-day survival rate, and dialysis dependence rate at discharge were all improved to varying degrees, and the activity effect was significant.

参考文献/References:

［1］Xu X, Nie S, Liu ZG，et al. Epidemiology and clinical correlates of AKI in Chinese hospitalized adults［J］.Clin J Am Soc Nephrol, 2015,10: 1510-1518. ［2］Moore PK, Hsu RK, Liu KD. Management of acute kidney injury: core curriculum 2018［J］.Am J Kidney Dis,2018,72(1): 136-148. ［3］Skube SJ, Katz SA, Chipman JG, et al. Acute kidney injury and sepsis［J］.Surgical Infections,2018,19(2): 216-224. ［4］Hall A, Crichton S, Dixon A, et al. Fluid removal associates with better outcomes in critically ill patients receiving continuous renal replacement therapy: a cohort study［J］.Crit Care,2020,24(1):279. ［5］Landucci F, Mancinelli P, De Gaudio AR, et al. Selenium supplementation in critically ill patients: a systematic review and meta-analysis［J］.J Crit Care,2014,29(1):150-156. ［6］Bagshaw SM, Darmon M,Ostermann M,et al. Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury［J］.Intensive Care Med,2017,43(6):841-854. ［7］Bagshaw SM, Chakravarthi MR, Ricci Z, et al. Precision continuous renal replacement therapy and solute control［J］.Blood Purif,2016,42(3): 238-247. ［8］Sansom B,Sriram S,Presneill J, et al. Circuit hemodynamics and circuit failure during continuous renal replacement therapy［J］.Crit Care Med,2019,47:e872-e879. ［9］Clark WR, Leblanc M, Ricci Z, et al. Quantification and dosing of renal replacement therapy in acute kidney injury: a reappraisal［J］.Blood Purif,2017,44(2):140-155. ［10］Shen B, Xu J, Wang Y, et al. Continuous renal replacement therapy quality control and performance measures［J］.Contrib Nephrol，2018,194:134-145. ［11］Rewa OG, Tolwani A, Mottes T, et al. Quality of care and safety measures of acute renal replacement therapy: workgroup statements from the 22nd acute disease quality initiative (ADQI) consensus conference［J］.J Crit Care,2019,54: 52-57. ［12］Rhee H, Jang GS, Han M, et al. The role of the specialized team in the operation of continuous renal replacement therapy: a single-center experience［J］.BMC Nephrol,2017 ,18(1):332. ［13］Lyndon WD, Wille KM, Tolwani AJ. Solute clearance in CRRT: prescribed dose versus actual delivered dose［J］.Nephrol Dial Transplant,2012,27(3):952-956. ［14］Macedo E, Granado RCD, Mehta RL. Effluent volume and dialysis dose in CRRT: time for reappraisal［J］.Nat Rev Nephrol,2011,8(1):57-60. ［15］Ruiz EF, Ortiz-Soriano VM, Talbott M, et al. Development, implementation and outcomes of a quality assurance system for the provision of continuous renal replacement therapy in the intensive care unit［J］.Sci Rep,2020,10(1):20616. ［16］Fealy N, Aitken L, Toit E, et al. Continuous renal replacement therapy: current practice in Australian and New Zealand intensive care units［J］.Crit Care Resusc,2015,17:83-91. ［17］Mauro N, Anna L, Massimo de Ca,et al. ACU smart continuous renal replacement therapy platform: multicenter pilot study for technical and clinical assessment (A.M.P. Study)［J］.Blood Purif,2019,48(1):60-66. ［18］Saudan P,Niederberger M,De Seigneux S,et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure［J］.Kidney Int,2006,70(7):1312-1317. ［19］Granado CD. Dose in continuous renal replacement therapy［J］. Gac Med Mex,2018,154(Supp 1): S40-S47. ［20］Nash DM, Przech S, Wald R,et al. Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit［J］.J Crit Care,2017,41: 138-144. ［21］Griffin BR, Thomson A, Yoder M, et al. Continuous renal replacement therapy dosing in critically ill patients: a quality improvement initiative［J］.Am J Kidney Dis,2019,74(6): 727-735. ［22］Quenot JP, Helms J, Bourredjem A, et al. Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial［J］.Ann Intensive Care,2019,9(1):75. ［23］Wang Y, Gallagher M, Li Q, et al. Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: a systematic review and individual patient data meta-analysis［J］.Nephrol Dial Transplant,2018,33(6):1017-1024. ［24］Kakajiwala A, Jemielita T, Hughes JZ, et al. Membrane pressures predict clotting of pediatric continuous renal replacement therapy circuits［J］.Pediatr Nephrol,2017,32(7): 1251-1261. ［25］Zhang Z, Ni H, Fan H,et al. Actually delivered dose of continuous renal replacement therapy is underestimated in hemofiltration［J］.ASAIO J,2013,59(6): 622-626. ［26］何 梅，王 东，鲜于剑波，等.失效模式与效应分析在新冠肺炎疫情防控中的应用探讨［J］.中国卫生质量管理，2020,27（4）：27-30.

相似文献/References:

[1]陈园园 孙蓉蓉 孟繁荣.某院医师质量管理工具培训效果分析[J].中国卫生质量管理,2016,23(06):021.[doi:10.13912/j.cnki.chqm.2016.23.6.08]
[2]蒋海泥李刚*夏海朋谢子秋孙熹.医院质量管理新思路：精细化管理与品管圈联合应用[J].中国卫生质量管理,2017,24(02):071.[doi:10.13912/j.cnki.chqm.2017.24.2.22]
[3]高岩鲍 玉荣 张莉彩 赵庆华 冯丹.小品管，大质量：医院开展品管圈活动效果研究[J].中国卫生质量管理,2017,24(04):001.[doi:10.13912/j.cnki.chqm.2017.24.4.01]
[4]马薇 叶丽艳 马艳宁 叶坤 张有江 杨继勇 罗燕萍.品管圈助力医技质量管理水平提升[J].中国卫生质量管理,2017,24(04):004.[doi:10.13912/j.cnki.chqm.2017.24.4.02]
[5]王玉玲 皮红英.品管圈助力护理质量管理水平提升[J].中国卫生质量管理,2017,24(04):006.[doi:10.13912/j.cnki.chqm.2017.24.4.03]
[6]袁继红 李洁 胡焱 许俊娟 李明丽 蒋丹丹 张平 常文明.品管圈助力营养配餐管理水平提升[J].中国卫生质量管理,2017,24(04):008.[doi:10.13912/j.cnki.chqm.2017.24.4.04]
[7]冯丹 何史林 高岩.信息化助力品管圈活动开展[J].中国卫生质量管理,2017,24(04):011.[doi:10.13912/j.cnki.chqm.2017.24.4.05]
[8]赵庆华 周颖 高岩.通过品管理念提升ICU护理质量[J].中国卫生质量管理,2017,24(04):013.[doi:10.13912/j.cnki.chqm.2017.24.4.06]
[9]李明学.价值工程在课题达成型品管圈方案优选中的应用[J].中国卫生质量管理,2017,24(04):065.[doi:10.13912/j.cnki.chqm.2017.24.4.23]
[10]涂宣成 肖万超 王道雄 邹佩琳 吕家高.建设现代医院后勤质量管理体系[J].中国卫生质量管理,2018,25(01):001.[doi:10.13912/j.cnki.chqm.2018.25.1.01]
[11]沈洁 陈园园 祁亮 何健 徐庆祥 张明 孔炜炜 王轶 史炯 解佳奇 刘宝瑞 孙蓉蓉.构建多学科协作的原发性肝癌医疗新模式[J].中国卫生质量管理,2019,26(03):093.[doi:10.13912/j.cnki.chqm.2019.26.3.26]
[12]蔡诗凝 诸杜明 黄俊峰 郑毅隽 潘思梦 魏宁 孙湛.构建医联体协作VTE防治模式[J].中国卫生质量管理,2020,27(01):114.[doi:10.13912/j.cnki.chqm.2020.27.1.29]
[13]蔡立柏 刘延锦 孟吉平 崔妙然 底瑞青 李英 郭园丽 叶琳 刘阳阳 王彬.全膝关节置换术后恐动症多学科协作管理模式构建[J].中国卫生质量管理,2020,27(03):083.
　CAI Libai,LIU Yanjin,MENG Jiping,et al.Establishment of A Multidisciplinary Collaborative Management Model for Kinesiophobia in Patients Following Total Knee Arthroplasty[J].Chinese Health Quality Management,2020,27(01):083.
[14]张琼吕德珍余娜赵玉李群苗素琴.构建ERAS理念下机器人手术管理模式[J].中国卫生质量管理,2020,27(06):091.[doi:10.13912/j.cnki.chqm.2020.27.6.23]
　ZHANG Qiong,LV Dezhen,YU Na,et al.Constructing the Management Model of Robot Surgery under ERAS Concept[J].Chinese Health Quality Management,2020,27(01):091.[doi:10.13912/j.cnki.chqm.2020.27.6.23]
[15]关亚庆张晓阳闫淑娟王蕾黄田张吴玉燕.构建神经外科ICU危重患者过渡期Y型路径标准化护理模式[J].中国卫生质量管理,2020,27(06):096.[doi:10.13912/j.cnki.chqm.2020.27.6.24]
　GUAN Yaqing,ZHANG Xiaoyang,YAN Shujuan,et al.Constructing the Transitional Period Y-Type Pathway Standardized Nursing Model for Critical ICU Patients in Neurosurgery Department[J].Chinese Health Quality Management,2020,27(01):096.[doi:10.13912/j.cnki.chqm.2020.27.6.24]
[16]许莉莉卢苏徐仁德顾国嵘邵勉曹蕾吴鸿谊姚晨玲.构建医联体平台下急性胸痛患者智慧化管理模式[J].中国卫生质量管理,2021,28(01):064.[doi:10.13912/j.cnki.chqm.2021.28.1.18 ]
　XU Lili,LU Su,XU Rende.Constructing the Intelligent Management Mode of Patients with Acute Chest Pain under the Medical Consortium Platform[J].Chinese Health Quality Management,2021,28(01):064.[doi:10.13912/j.cnki.chqm.2021.28.1.18 ]
[17]蒋娅谢翠华罗祥蓉雷满霞李际敏邹梦晨曹瑛高方.基于三级预防的糖尿病足全程管理模式构建[J].中国卫生质量管理,2021,28(02):068.[doi:10.13912/j.cnki.chqm.2021.28.2.21 ]
　JIANG Ya,XIE Cuihua,LUO Xiangrong.Construction of Diabetic Foot Whole-Process Management Mode Based on Tertiary Prevention[J].Chinese Health Quality Management,2021,28(01):068.[doi:10.13912/j.cnki.chqm.2021.28.2.21 ]
[18]向萍 胡平玲 周启蒙 沈洁 叶玲 刘莉.课题研究型品管圈内训课程设计要点分析[J].中国卫生质量管理,2021,28(03):062.[doi:10.13912/j.cnki.chqm.2021.28.3.19 ]
　XIANG Ping,HU Pingling,ZHOU Qimeng.Key Points of Design of Project Research Type Quality Control Circle Internal Training Curriculum[J].Chinese Health Quality Management,2021,28(01):062.[doi:10.13912/j.cnki.chqm.2021.28.3.19 ]
[19]金宗兰陈萍萍李磊刘玲莉陈梅霞刘玲任海迪韩东郝宗耀 胡少华.基于“互联网+”神经源性膀胱骶神经调控患者智慧化管理模式构建[J].中国卫生质量管理,2021,28(05):079.[doi:10.13912/j.cnki.chqm.2021.28.5.22 ]
　JIN Zonglan,CHEN Pingping,LI Lei.Construction of Intelligent Management Mode Based on "Internet Plus" Sacral Nerve Modulation of Neurogenic Bladder Patients[J].Chinese Health Quality Management,2021,28(01):079.[doi:10.13912/j.cnki.chqm.2021.28.5.22 ]
[20]薛缪群计长琴刘景瑜王勤石青青陈园园蒋玥朱颖春山惠枝 贺方方陆菲菲孙小玲孔娜.基于医护患协作的辅助生育治疗中卵巢过度刺激综合征全流程诊疗模式构建[J].中国卫生质量管理,2021,28(06):085.[doi:10.13912/j.cnki.chqm.2021.28.6.23 ]
　XUE Miaoqun,JI Changqin,LIU Jingyu.Construction of a Whole-Process Diagnosis and Treatment Mode for Ovarian Hyperstimulation Syndrome in Assisted Reproductive Therapy Based on Doctor-Nurse-Patient Collaboration[J].Chinese Health Quality Management,2021,28(01):085.[doi:10.13912/j.cnki.chqm.2021.28.6.23 ]

更新日期/Last Update: 2022-01-28